Website Links
Description
The leader in developing new s-nitrosothiol (SNO)-based drugs N30's drugs target S-nitrosoglutathione reductase (GSNOR), an enzyme of central importance in human health and disease. 2010.08.17 Crystal structure of N6022 bound to GSNOR and NAD+ was resolved with resolution of 1.9 Å at ALS 5.0.1